Search Results - "Perkal, H."

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? by TINTORE, M, ROVIRA, A, MONTALBAN, X, RIO, J, TUR, C, PELAYO, R, NOS, C, TELLEZ, N, PERKAL, H, COMABELLA, M, SASTRE-GARRIGA, J

“…To evaluate whether oligoclonal bands (OB) add information to MRI in predicting both a second attack and development of disability in patients with clinically…”
Get full text

Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3‐like 1 and neurofilament light chain by Quintana, E., Coll, C., Salavedra‐Pont, J., Muñoz‐San Martín, M., Robles‐Cedeño, R., Tomàs‐Roig, J., Buxó, M., Matute‐Blanch, C., Villar, L. M., Montalban, X., Comabella, M., Perkal, H., Gich, J., Ramió‐Torrentà, L.

“…Background and purpose Chitinase 3‐like 1 (CHI3L1) and neurofilament light chain (NF‐L) are promising biomarkers of disability in multiple sclerosis (MS)…”
Get full text

Clinical impact of early brain atrophy in clinically isolated syndromes by Pérez-Miralles, F, Sastre-Garriga, J, Tintoré, M, Arrambide, G, Nos, C, Perkal, H, Río, J, Edo, MC, Horga, A, Castilló, J, Auger, C, Huerga, E, Rovira, A, Montalban, X

“…Background: The impact of global and tissue-specific brain atrophy on conversion to multiple sclerosis (MS) after a clinically isolated syndrome (CIS) is not…”
Get full text

Onset-adjusted incidence of multiple sclerosis in the Girona province (Spain): Evidence of increasing risk in the south of Europe by Otero-Romero, S, Ramió-Torrentà, Ll, Pericot, I, Carmona, O, Perkal, H, Saiz, A, Bufill, E, Robles, R, Simón, E, Llufriu, S, Vaqué-Rafart, J, Sastre-Garriga, J, Montalban, X

“…Abstract Background Recent studies show an increasing incidence of multiple sclerosis (MS) in southern Europe. Although by its geographical location and…”
Get full text

Do multimodal evoked potentials add information to MRI in clinically isolated syndromes? by Pelayo, R., Montalban, X., Minoves, T., Moncho, D., Rio, J., Nos, C., Tur, C., Castillo, J., Horga, A., Comabella, M., Perkal, H., Rovira, A., Tintoré, M.

“…The role of multimodal evoked potentials (MMEPs) in establishing multiple sclerosis (MS) diagnosis and prognosis has diminished nowadays. The objective of this…”
Get full text

Clinical features of CIS of the brainstem/cerebellum of the kind seen in MS by Sastre-Garriga, Jaume, Tintoré, M., Nos, C., Tur, C., Río, J., Téllez, N., Castilló, J., Horga, A., Perkal, H., Comabella, M., Rovira, A., Montalban, X.

“…Recognition of multiple sclerosis (MS) attacks relies mostly on clinical assessment. However, their definition based on McDonald criteria refers mostly to…”
Get full text

Very early scans for demonstrating dissemination in time in multiple sclerosis by Tur, C, Tintoré, M, Rovira, Á, Nos, C, Río, J, Téllez, N, Galán, I, Perkal, H, Comabella, M, Sastre-Garriga, J, Montalban, X

“…Objective To evaluate the clinical significance of the 2005 modified imaging criteria for dissemination in time in multiple sclerosis stating that detection of…”
Get full text

Multiple sclerosis epidemiological situation update: pertinence and set-up of a population based registry of new cases in Catalonia by Otero, S, Batlle, J, Bonaventura, I, Brieva, Ll, Bufill, E, Cano, A, Carmona, O, Escartín, A, Marco, M, Moral, E, Munteis, E, Nos, C, Pericot, I, Perkal, H, Ramió-Torrentà, Ll, Ramo-Tello, C, Saiz, A, Sastre-Garriga, J, Tintoré, M, Vaqué, J, Montalban, X

“…The first epidemiological studies on multiple sclerosis (MS) around the world pictured a north to south latitudinal gradient that led to the first genetic and…”
Get full text

Spanish adaptation of the disease-specific questionnaire MSQOL-54 in multiple sclerosis patients by Aymerich, M, Guillamón, I, Perkal, H, Nos, C, Porcel, J, Berra, S, Rajmil, L, Montalbán, X

“…The Multiple Sclerosis Quality of Life 54 (MSQOL-54) is a health-related quality of life specific questionnaire for multiple sclerosis (MS) patients. The…”
Get more information

Acute disseminated encephalomyelitis: study of factors involved in a possible development towards multiple sclerosis by Tur, C, Téllez, N, Rovira, A, Tintoré, M, Río, J, Nos, C, Perkal, H, Castilló, J, Horga, A, León, A, Galán, I, Sastre-Garriga, J, Montalbán, X

“…Acute disseminated encephalomyelitis (ADEM) is an uncommon disease characterized by inflammation and demyelination of the central nervous system (CNS). It…”
Get more information

Response to treatment with interferon beta in patients with multiple sclerosis. Validation of the Rio Score by Rio, J, Rovira, A, Blanco, Y, Sainz, A, Perkal, H, Robles, R, Ramio-Torrenta, Ll, Diaz, R M, Arroyo, R, Urbaneja, P, Fernandez, O, Garcia-Merino, J A, Reyes, M P, Oreja-Guevara, C, Prieto, J M, Izquierdo, G, Olascoaga, J, Alvarez-Cermeno, J C, Simon, E, Pujal, B, Comabella, M, Montalban, X

“…Different criteria have been proposed for the response to treatment with interferon beta, and the Rio Score is one of the most widely used. The aim of this…”
Get full text

Genetic association between polymorphisms in the ADAMTS14 gene and multiple sclerosis by Goertsches, Robert, Comabella, Manuel, Navarro, Arcadi, Perkal, Hector, Montalban, Xavier

“…ADAMTS14 is a novel member of the ADAMTS (a disintegrin-like and metalloproteinase domain with thrombospondin type 1 modules) metalloproteinase family which…”
Get full text

Clinical features and natural history of primary progressive multiple sclerosis by Tur, C, Sastre-Garriga, J, Castillo, J, Tintore, M, Nos, C, Rio, J, Galan, I, Horga, A, Tellez, N, Perkal, H, Comabella, M, Rovira, A, Montalban, X

“…Background: About 10 to 15% of patients with multiple sclerosis (MS) have a predominantly progressive course from onset, although a few relapses can occur…”
Get full text

Infratentorial lesions are a marker for poor prognosis in multiple sclerosis by Tintore, M, Rovira, A, Leon, A, Rio, J, Gutierrez, D, Nos, C, Perkal, H, Castillo, J, Horga, A, Comabella, M, Jaume, S-G, Montalban, X

“…Background: The number of baseline lesions predicts future attacks and disability in clinically isolated syndromes (CIS). The presence of two or more…”
Get full text

TNF-α converting enzyme (ΤΑCΕ) protein expression in different clinical subtypes of multiple sclerosis by COMABELLA, Manuel, ROMERA, Cristina, CAMINA, Montse, PERKAL, Hector, MORO, Maria A, LEZA, Juan C, LIZASOAIN, Ignacio, CASTILLO, Mireia, MONTALBAN, Xavier

“…Tumor necrosis factor (TNF)-alpha converting enzyme (TACE, also called ADAM17) is a key sheddase that releases TNF-alpha from its inactive cell-bound…”
Get full text

TNF-[alpha] converting enzyme (TACE) protein expression in different clinical subtypes of multiple sclerosis by Comabella, M, Romera, C, Camiña, M, Perkal, H, Moro, M A, Leza, J C, Lizasoain, I, Castillo, M, Montalban, X

“…Tumor necrosis factor (TNF)-α converting enzyme (TACE, also called ADAM17) is a key sheddase that releases TNF-α from its inactive cell-bound precursor. TACE…”
Get full text

Situación epidemiológica actual de la esclerosis múltiple: pertinencia y puesta en marcha de un registro poblacional de nuevos casos en Cataluña by Otero Romero, Susana, Batlle, J., Bonaventura, I., Brieva Ruiz, Lluís, Bufill Soler, Enric, Cano Orgaz, Antonio T., Carmona Codina, O., Escartín Siquier, Antonio E., Marco, M., Moral, E., Munteis Olivas, Elvira, Nos, C., Pericot Nierga, Imma, Perkal, Héctor, Ramió Torrentà, Lluís, Ramo Tello, Cristina, Saiz Hinarejos, Albert, Sastre Garriga, Jaume, Tintoré Subirana, Mª del Mar, Vaqué, J., Montalban Gairin, Xavier, en representación del Grupo de tra, en representación del Grupo de tra

Get full text